K A A Andersen
Biographic Data
| ID | 5916 |
|---|---|
| NAME | K A A Andersen |
| GIVEN NAMES | K A A |
| FAMILY NAME | Andersen |
| SIGNATURE | ANDERSEN K A A |
| AFFILIATIONS | Oslo University Hospital |
| ORCID | 0000-0002-9313-4459 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Recreational MDMA use in Norway
Our sample reported positive experiences and effects of recreational MDMA use, with a small minority reporting problematic effects and negative experiences. Self-perceived symptoms were reported as improved, especially for internalizing disorders. Participants reported positive changes in many aspects of life
Assessment of psychedelic--induced states
BackgroundPrevious international clinical trials have indicated that mystical experiences resulting from the consumption of classic psychedelic drugs, such as psilocybin, may represent a subjective psychological mechanism of action associated with therapeutic effects for various mental disorders. The revised 30-item Mystical Experience Questionnaire is one of several psychometric scales designed to evaluate such subjective experiences induced by …
Epidemiology of classic psychedelic substances
In this cross-sectional sample of Norwegian, self-selecting adults, we shed light on what characterizes the most memorable experience with a classic psychedelic substance, including short- and long-term risks and benefits. For the most part, the psychedelic experience led to improvements in self-perceived symptoms of mental disorders and substance use disorders. However, a small subset experienced persisting adverse reactions
No prominent works on this page.
Epidemiology of classic psychedelic substances
In this cross-sectional sample of Norwegian, self-selecting adults, we shed light on what characterizes the most memorable experience with a classic psychedelic substance, including short- and long-term risks and benefits. For the most part, the psychedelic experience led to improvements in self-perceived symptoms of mental disorders and substance use disorders. However, a small subset experienced persisting adverse reactions
Assessment of psychedelic--induced states
BackgroundPrevious international clinical trials have indicated that mystical experiences resulting from the consumption of classic psychedelic drugs, such as psilocybin, may represent a subjective psychological mechanism of action associated with therapeutic effects for various mental disorders. The revised 30-item Mystical Experience Questionnaire is one of several psychometric scales designed to evaluate such subjective experiences induced by …
Recreational MDMA use in Norway
Our sample reported positive experiences and effects of recreational MDMA use, with a small minority reporting problematic effects and negative experiences. Self-perceived symptoms were reported as improved, especially for internalizing disorders. Participants reported positive changes in many aspects of life
Psychedelics and Drug Studies (3 works) · Chemical synthesis and alkaloids (2 works) · Clinical Psychology (2 works) · Hallucinogen (2 works) · Norwegian (2 works) · Psilocybin (2 works) · Psychiatry (2 works) · Psychology (2 works) · Recreation (2 works) · Sample (material (2 works)